Research and Significance of Vaccines Against Sexually Transmitted Diseases
A special issue of Vaccines (ISSN 2076-393X). This special issue belongs to the section "Human Vaccines and Public Health".
Deadline for manuscript submissions: 31 August 2026 | Viewed by 33
Special Issue Editors
Interests: prevention interventions to address behaviors associated with HIV/STI, substance abuse, and mental health issues among vulnerable populations; HPV vaccination promotion and cancer prevention; cross-cultural health research; technology-based health interventions
2. Ellmer School of Nursing, Old Dominion University, Virginia Beach, VA, USA
Interests: Public health nursing; HPV vaccine promotion; Prevention interventions to address behaviors associated with HIV/STI; STI testing and treatment
Special Issue Information
Dear Colleagues,
Vaccines represent a cornerstone in the prevention of sexually transmitted infections (STIs), offering safe, effective, and scalable tools to reduce disease burden. Currently, three STIs have approved vaccines: human papillomavirus (HPV), hepatitis B virus (HBV), and hepatitis A virus (HAV). These vaccines have demonstrated significant public health impact by preventing HPV-related cancers and genital warts, HBV-related liver disease, and sexually transmitted HAV outbreaks, particularly among men who have sex with men (MSM). However, barriers such as low coverage, misinformation, and access inequities continue to limit their potential.
This Special Issue invites original research, reviews, and commentary focused on both approved and investigational STI vaccines. Topics may include vaccine effectiveness, uptake disparities, implementation strategies, population-specific interventions, and policy innovations. Submissions should align with the journal’s mission to promote the science of vaccine development, application, and impact across populations.
We welcome original research articles, reviews, and commentaries. Areas of interest include, but are not limited to: (1) synthesizing current evidence on the use and impact of both approved and investigational STI vaccines, (2) identifying strategies to improve vaccine uptake and equity, and (3) informing future public health and clinical efforts to maximize the benefits of these critical preventive tools.
We look forward to receiving your contributions.
Prof. Dr. Angela Chia-Chen Chen
Prof. Dr. Elizabeth Reifsnider
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- sexually transmitted infections (STIs)
- HPV vaccine
- hepatitis B vaccine
- hepatitis A vaccine
- vaccine uptake
- interventions
- equity in vaccination
- preventive health
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
